Onconova Therapeutics Stock Price - ONTX

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 0.39 ▲ 0.01 (1.69%)
Company Name Stock Ticker Symbol Market Type
Onconova Therapeutics Inc ONTX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0284 -6.96% 0.3796 0.42 0.3759 0.4169 0.408 19:59:20
Bid Price Ask Price Spread Spread % News
0.3855 0.386 0.0005 0.13% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
15,479 14,718,759 $ 0.399039 $ 5,873,359 23,836,054 0.1027 - 5.25
Last Trade Time Type Quantity Stock Price Currency
19:59:20 formt 1,000 $ 0.386 USD

Onconova Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 52.66M 138.73M $ -20.57M -7.93 - 137.22M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Onconova Therapeutics News

Date Time Source News Article
1/23/202008:39Edgar (US Regulatory)Current Report Filing (8-k)
1/23/202008:30GlobeNewswire Inc.Onconova Therapeutics Regains Rigosertib Rights in Greater..
1/17/202017:26Edgar (US Regulatory)Current Report Filing (8-k)
1/13/202016:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
1/10/202016:04Edgar (US Regulatory)Statement of Ownership (sc 13g)
1/03/202017:30Edgar (US Regulatory)Current Report Filing (8-k)
1/03/202013:27GlobeNewswire Inc.Onconova Therapeutics, Inc. Announces Closing of $10 Million..

Latest ONTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.4160.4450.32470.411944217,785,872-0.0364-8.75%
1 Month0.330.690.31580.437776927,273,4380.049615.03%
3 Months0.530.770.10270.352007418,812,870-0.1504-28.38%
6 Months2.352.840.10270.36933728,510,200-1.97-83.85%
1 Year1.965.250.10270.39586284,426,911-1.58-80.63%
3 Years38.4058.200.10272.681,858,089-38.02-99.01%
5 Years52.95122.550.10274.191,181,188-52.57-99.28%

Onconova Therapeutics Description

Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks cellular signaling by targeting RAS effector pathways.
Your Recent History
NASDAQ
ONTX
Onconova T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200125 02:58:44